nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of trastuzumab emtansine (T-DM1) in 3D cell culture
|
Boyer, Jean Zheng |
|
|
188 |
1 |
p. 65-75 |
artikel |
2 |
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors
|
Kim, Kyae Hyung |
|
|
188 |
1 |
p. 203-214 |
artikel |
3 |
Barriers and engagement in breast cancer survivorship wellness activities
|
Szuhany, Kristin L. |
|
|
188 |
1 |
p. 317-325 |
artikel |
4 |
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry
|
Kaufman, Peter A. |
|
|
188 |
1 |
p. 179-190 |
artikel |
5 |
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study
|
Chetrit, Angela |
|
|
188 |
1 |
p. 273-282 |
artikel |
6 |
Characterization of estrogen receptor-low-positive breast cancer
|
Fei, Fei |
|
|
188 |
1 |
p. 225-235 |
artikel |
7 |
Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
|
Ahn, Sung Gwe |
|
|
188 |
1 |
p. 165-178 |
artikel |
8 |
Comparison of mastectomy and breast reconstruction outcomes using low thermal dissection versus traditional electrocautery: a blinded randomized trial
|
Habibi, Mehran |
|
|
188 |
1 |
p. 101-106 |
artikel |
9 |
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS
|
Rakovitch, Eileen |
|
|
188 |
1 |
p. 133-139 |
artikel |
10 |
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
|
Masuda, Norikazu |
|
|
188 |
1 |
p. 117-131 |
artikel |
11 |
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
|
Sundaresan, Tilak K. |
|
|
188 |
1 |
p. 43-52 |
artikel |
12 |
Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study
|
Lizarraga, Ingrid M. |
|
|
188 |
1 |
p. 191-202 |
artikel |
13 |
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
|
Battisti, Nicolò Matteo Luca |
|
|
188 |
1 |
p. 149-163 |
artikel |
14 |
LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis
|
Wang, You-Quan |
|
|
188 |
1 |
p. 1-14 |
artikel |
15 |
Male and female breast cancer: the two faces of the same genetic susceptibility coin
|
Silva, Susana Nunes |
|
|
188 |
1 |
p. 295-305 |
artikel |
16 |
Mammography use and breast cancer incidence among older U.S. women
|
Turbow, Sara D. |
|
|
188 |
1 |
p. 307-316 |
artikel |
17 |
Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women
|
Luo, Juhua |
|
|
188 |
1 |
p. 283-293 |
artikel |
18 |
M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma
|
Arole, Vidya |
|
|
188 |
1 |
p. 37-42 |
artikel |
19 |
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
|
Park, Ko Un |
|
|
188 |
1 |
p. 249-258 |
artikel |
20 |
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting
|
Almodallal, Yahya |
|
|
188 |
1 |
p. 15-20 |
artikel |
21 |
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI
|
Tokuda, Yukiko |
|
|
188 |
1 |
p. 107-115 |
artikel |
22 |
Prosigna test in breast cancer: real-life experience
|
Hequet, D |
|
|
188 |
1 |
p. 141-147 |
artikel |
23 |
Reply to the letter on sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer
|
Damin, Andrea P. |
|
|
188 |
1 |
p. 327-328 |
artikel |
24 |
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES
|
Im, Young-Hyuck |
|
|
188 |
1 |
p. 77-89 |
artikel |
25 |
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
|
Chalasani, Pavani |
|
|
188 |
1 |
p. 91-99 |
artikel |
26 |
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing
|
Lertwilaiwittaya, Pongtawat |
|
|
188 |
1 |
p. 237-248 |
artikel |
27 |
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
|
Smith, Samuel G. |
|
|
188 |
1 |
p. 215-223 |
artikel |
28 |
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
|
Al-Kawaz, Abdulbaqi |
|
|
188 |
1 |
p. 53-63 |
artikel |
29 |
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies
|
Dempsey, Naomi |
|
|
188 |
1 |
p. 21-36 |
artikel |
30 |
Variations in breast cancer surgical treatment and timing: determinants and disparities
|
Dankwa-Mullan, Irene |
|
|
188 |
1 |
p. 259-272 |
artikel |